Reaction
Cervical Dysplasia reporting signals
As of the last recalculation, Cervical Dysplasia appears in 2,155 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL AND ETHINYL ESTRADIOL (PRR 84.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Etonogestrel And Ethinyl Estradiol | 178 | 84.4 | 85.1 |
| Copper | 128 | 30.4 | 30.5 |
| Levonorgestrel | 304 | 16.8 | 16.8 |
| Basiliximab | 19 | 15.7 | 15.8 |
| Anti-Thymocyte Globulin (Rabbit) | 12 | 14.4 | 14.5 |
| Fingolimod Hcl | 104 | 12.2 | 12.2 |
| Adalimumab-Fkjp | 53 | 11.3 | 11.3 |
| Alemtuzumab | 22 | 11.1 | 11.1 |
| Adalimumab-Aaty | 53 | 11.1 | 11.1 |
| Adalimumab-Adaz | 53 | 9.9 | 9.9 |
| Cladribine | 9 | 9.1 | 9.1 |
| Infliximab | 175 | 8.3 | 8.3 |
| Busulfan | 13 | 8.0 | 8.0 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 18 | 7.4 | 7.4 |
| Medroxyprogesterone Acetate | 36 | 7.1 | 7.1 |
| Efavirenz | 8 | 7.0 | 7.0 |
| Ustekinumab | 61 | 5.9 | 5.9 |
| Mesna Injection | 5 | 5.9 | 5.9 |
| Mesna | 5 | 5.7 | 5.7 |
| Lopinavir And Ritonavir | 8 | 5.7 | 5.7 |
| Darunavir | 8 | 5.1 | 5.1 |
| Baricitinib | 5 | 5.0 | 5.0 |
| Ocrelizumab | 30 | 4.7 | 4.7 |
| Bleomycin Sulfate | 5 | 4.7 | 4.7 |
| Nevirapine | 4 | 4.3 | 4.3 |
| Drospirenone And Ethinyl Estradiol | 19 | 4.2 | 4.2 |
| Natalizumab | 76 | 4.1 | 4.2 |
| Vedolizumab | 35 | 4.0 | 4.0 |
| Isotretinoin | 18 | 3.5 | 3.5 |
| Cariprazine | 3 | 3.1 | 3.1 |
| Belimumab | 10 | 3.1 | 3.1 |
| Etonogestrel | 11 | 2.2 | 2.2 |
| Dimethyl Fumarate | 24 | 1.9 | 1.9 |